Upcoming Events
Log In
Pricing
Free Trial

Wk 4, Case 5 - Practice

HIDE

Male with well-differentiated grade 2 metastatic neuroendocrine tumor to the liver, kidney and bladder of unknown primary. Currently treated with octreotide.

A PET CT was ordered using the DOTATATE tracer.

What is the likely site of the primary neuroendocrine tumor based on the baseline imaging?

PrevNext

Report

Faculty

Riham El Khouli, MD

Associate Professor of Radiology, Chief, Division of Nuclear Medicine/Molecular Imaging & Radiotheranostics

University of Kentucky

Michael F. Shriver, MD

Director of Nuclear Medicine

Proscan-NCH Imaging

Tags

PET

Nuclear Medicine

CT

© 2025 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy